ANPEP and prostate cancer: This was expected as the PC3 prostate cancer line has high expression of CD13, making it an ideal therapeutic target for NGR-directed delivery of truncated coagulase to efficiently induce thrombosis, reduce tumor cell proliferation and increase cell death in these highly aggressive and widely used human tumor cell line models.